Press Releases

Date Title and Summary Additional Formats
Toggle Summary Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development
Company adopts Edge CTMS in Japan as part of rapid global expansion NEW YORK --(BUSINESS WIRE)--Feb. 20, 2018-- Santen Pharmaceutical Co., Ltd , is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial
Toggle Summary Medidata and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement to Adopt Medical Imaging and Workflow Solutions
Industry-leading Data Management Provider Adopts Rave Imaging to Optimize Workflow, Simplify Image and Data Collection, and Improve Efficiency in Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 15, 2018-- Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC , an
Toggle Summary Medidata Named One of 100 Most Sustainable Companies in the U.S. by Barron's Magazine
NEW YORK --(BUSINESS WIRE)--Feb. 14, 2018-- Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “ 100 Most Sustainable Companies ” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
Toggle Summary Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement
Leading clinical research organization moves to the industry’s only unified platform to maximize efficiencies and outcomes NEW YORK --(BUSINESS WIRE)--Feb. 13, 2018-- Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the
Toggle Summary Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018
Life Science Buyers Identify Top Criteria to Support the New Generation of Trials Edge Strategic Monitoring is Only RBM Solution to Address 95% of TransCelerate Technical Requirements and be Fully Compliant with ICH GCP E6 (R2) Requirements NEW YORK --(BUSINESS WIRE)--Feb.
Toggle Summary Medidata Solutions to Host Annual European NEXT Conference Series
Events in Basel , Frankfurt and London Bring Together Industry Leaders to Reinvent Technology’s role in Transforming Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 12, 2018-- Medidata Solutions (NASDAQ:MDSO), is pleased to announce the 13 th annual NEXT Conference series will commence in
Toggle Summary Medidata Ushers in Era of Choice as Life Science Companies Can Now Conduct Both Virtual and On-site Clinical Trials on One eClinical Platform
Majority of virtual trials are now run on Medidata Clinical Cloud®, the industry’s only unified eClinical platform to fully support all manner of pragmatic study designs NEW YORK --(BUSINESS WIRE)--Feb. 8, 2018-- Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is
Toggle Summary Medidata Reports Record Full-Year and Fourth Quarter 2017 Results
Full-year total revenue of $545.5 million , representing 18% year-over-year growth Full-year GAAP net income of $44.4 million , or $0.74 per diluted share, up 53% year-over-year Total multi-year unadjusted subscription backlog 1 of $1.0 billion as of December 31, 2017 , up 39% year-over-year
Toggle Summary Medidata’s Next Generation Site Selection and Operational Benchmarking Tools Generally Available
Advanced Analytics Empower Life Sciences Companies and CROs to Tackle Today’s Most Complex Trials NEW YORK --(BUSINESS WIRE)--Feb. 6, 2018-- Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise.
Toggle Summary Medidata and Syapse Announce Partnership to Bring Oncology Clinical Trials Into Precision Medicine Era
Partnership will democratize access to clinical trials and help community health systems find and enroll eligible patients at unprecedented scale NEW YORK and SAN FRANCISCO , Jan. 31, 2018 /PRNewswire/ --  Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data

Investor Contact

Betsy Frank
+1 917 522 4620